The use of anticoagulant therapy in the treatment of thrombosis is now widespread, and there is little doubt of its value. It is therefore not surprising that many laboratory workers have attempted to find tests to demonstrate hypercoagulability of the blood, so that, in susceptible cases, anticoagulants might be used to prevent the onset of thrombosis.
It appears that blood does not clot solid in the vessels of normal people because the surface with which it is in contact does not readily liberate the thromboplastin which is essential for the conversion of prothrombin to thrombin. When blood is withdrawn from the body and maintained at 370 C. in a glass tube, clotting occurs in five to 10 minutes because contact of blood with the glass surface leads to the liberation of a powerful thromboplastin. After coagulation of normal blood in a glass tube most of the prothrombin activity disappears from the serum; the extent to which this has-occurred may be an index of the efficiency of the blood thromboplastin system. When blood is held at 370 C. in tubes coated with silicone, it takes upwards of 20 minutes to clot and only a fraction of the prothrombin activity disappears: it is thought that this is because the silicone surface does not readily promote the liberation of thromboplastin. Thus it is probably true to say that clotting of normal blood is limited by the extent to which free, active thromboplastin can be formed. The diagnosis of a "prethrombotic state" may therefore depend on demonstrating some abnormality of the blood thromboplastin system. Since there were at the time when these investigations were made no specific tests for the investigation of this system, indirect methods were used.
Three techniques are available. The first method is to compare the clotting time of whole unaltered * Member of external staff, Medical Research Council. blood in vessels of different surfaces. The second method is to study the extent to which prothrombin is converted to thrombin during clotting, especially during clotting in siliconed vessels. The third method is to measure the reaction of blood to heparin; this substance delays the conversion of prothrombin to thrombin and also inhibits the thrombin-fibrinogen reaction.
It has been claimed that, in patients who develop thrombosis, the whole blood clotting time (Cummine and Lyons, 1948; Barker and Margulies, 1949) (1), with the tubes silicone-coated (Jaques, Fidlar, Feldsted, and Macdonald, 1946a, b) . (3) The method of Dale and Laidlaw (1911-12) (Waugh and Ruddick, 1944a, b) .-Saline solutions of heparin were prepared in the series 0.2, 0.4, 0.6 . . . 2.0 units per ml., and 0.5 ml. of each placed in 7.5 x 0.9 cm. glass tubes in the 37°C. water-bath. Initially 1.0 ml. of blood was added to each tube directly from the syringe, but later citrated blood (1.0 ml. sodium citrate solution to 9.0 ml. blood) was used and the heparin solutions calcified; in this technique the tube series was usually reduced to the six lowest concentrations only. The clotting times were determined as in the Lee and White tests. The reacting heparin concentrations were determined by calculating the total fluid volume in the tubes from the haematocrit of the citrated blood.
Haematocrit values were retrospectively estimated for the analysis of certain early cases by reference to the clinical details recorded, as measurements had not been made in these instances (the error introduced was small compared with differences between persons). One to four saline control tubes were also tested with the heparin tubes.
Subjects
Three clinical groups of subjects were tested normal controls, abnormal controls, and thrombotics. The Not all subjects were investigated by all the tests: the numbers are given in the tables. Individuals re-tested either in the same clinical group at intervals of several months or in more than one clinical group counted each time as a separate subject, but when patients were re-tested after intervals of a few days, while the clinical condition was materially unaltered, the duplicated readings were pooled. Some 15 to 20 individuals were tested twice (the degree of overlapping between the normal subgroups is only approximately known), the readings from five of whom were pooled, and one subject was tested three times.
Normal Controls.-Blood was obtained from laboratory staff, from ex-patients at follow-up, from patients' relatives, and from apparently healthy persons undergoing routine tests for blood grouping and serology. These controls fell into two subgroups. Subgroup 1 consisted of 32 subjects tested concurrently with the abnormal and the thrombotic subjects, and by the same observers. Subgroup 2 consisted of 50 subjects tested at a different time, and to some extent by different observers in the same laboratory. The whole blood clotting time was measured by the method of Dale and Laidlaw on all the subjects, and by that of Lee and White on 36 subjects. A comparison between the two subgroups thus provides a measure of differences that may be expected in the results in these two well-established tests when made on normal persons under slightly different conditions. Abnormal Controls.-Tests were made on medical and surgical bed patients and on maternity cases shortly before or after delivery, none of whom was believed to have had thrombosis at the time of testing : there were in all 40 patients.
Three patients with thrombocytopenia were also tested by the whole blood clotting time and heparin resistance tests, as a control of the sensitivity of the latter in demonstrating the change known to be found in this condition. They were all tested against heparin with citrated blood.
Thrombotic Cases.-Forty subjects of various clinical types were tested : the method of classification of the material is shown in Table II Tables I and III, with Tables I and II. Table I shows the comparisons between the broad clinical groups, and in Table lI the statistics are given for each thrombotic subgroup.
The two subgroups of normal subjects gave mean values which were found to be significantly different: this difference must be ascribed to undetected differences in the conditions of testing. The abnormal controls had a higher mean value than either of the normal control groups, and again the differences were significant. These results illustrate the difficulty of applying such tests to the study of any but large differences between patients. It must be supposed that in obtaining the results from the two groups of normal subjects the endpoints were read in a slightly different way or that some other unidentified factor influenced the results.
There was no significant difference between the abnormal control group and the patients with thrombosis (Table I) .
Clotting Table II . It was found that for normal people the curves relating clotting time to heparin concentration varied greatly between persons, both when whole blood and when citrated whole blood were used (Fig. 1) 
